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Functional  studies  of Streptococcus  pneumoniae  virulence  factors  are  facilitated  by the  development
of  complementation/mutagenesis  systems.  These  methods  usually  result  in poor  expression  yields;
therefore,  biochemical  and  structural/functional  characterizations  are  mostly  performed  with  proteins
expressed  and  puriﬁed  from  heterologous  systems  (e.g. Escherichia  coli).  However,  heterologous  expres-
sion does  not  guarantee  correct  protein  structure  and  function.  In this  work,  we  developed  a  method  to
over-express  and  purify  homologous  proteins  from  S. pneumoniae.  The  system  relies  on  the combined
use  of  the shuttle  plasmid  pMU1328  and  a natural  constitutive  pneumococcal  promoter,  P96.  Efﬁcient
over-expression  of secreted,  membrane  or surface  anchored  proteins,  either  wild  type  or  mutant,  was
achieved.  As proof  of principle  the S. pneumoniae  pilus-1  backbone  RrgB  was successfully  puriﬁed  as  aomologous over-expression
rgB pilus protein puriﬁcation
His-tag  secreted  protein  (RrgB-His  SP)  from  pneumococcal  culture  supernatants.  N-terminal  sequencing
and mass  spectrometry  analysis  of  RrgB-His  SP allowed  the  determination  of the  leader  sequence  cleav-
age site in  pneumococcus,  while  proteolysis  studies  conﬁrmed  the  stability  of RrgB-His  SP  to  trypsin
digestion.  The  data presented  here  support  the  use  of  this  novel  homologous  expression  method  for  all
S. pneumoniae  proteins  for which  extensive  characterization  studies  are  planned.  Moreover,  given the
promiscuity  of  the  pMU1328  replicon,  this  system  could  be  used  in diverse  bacterial  species.. Introduction
The Gram-positive human pathogen Streptococcus pneumoniae
S. pneumoniae) represents one of the four major infectious diseases
ogether with HIV, malaria, and tuberculosis. The pneumococcus
s one of the most important etiologic agents of respiratory tract
nfections and invasive diseases (i.e. sinusitis, otitis media, commu-
ity acquired pneumonia, septicemia and meningitis), as well as
 member of the human commensal ﬂora, asymptomatically col-
nizing the nasopharynx of children and healthy adults (Selman
t al., 2000; Johnson et al., 2010; Henriques-Normark and Normark,
010; O’Brien et al., 2009).
The study of the function of pneumococcal proteins not only
llows better understanding of the biology and related virulence
echanisms of S. pneumoniae, but also provides new strategies,
ike innovative protein-based vaccines, to combat pneumococcal
elated diseases (Denoel et al., 2011; Loisel et al., 2011; Holmlund
t al., 2009; Gieﬁng et al., 2008; Gentile et al., 2011).
∗ Corresponding author at: Novartis Vaccines and Diagnostics, Via Fiorentina 1,
iena, Italy. Tel.: +39 0577 245342; fax: +39 0577 249314.
E-mail address: monica.moschioni@novartis.com (M.  Moschioni).
168-1656     © 2011 Elsevier B.V.  
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Open access under CC BY-NC-ND license.© 2011 Elsevier B.V. 
Thus far, the host of choice for pneumococcal protein expres-
sion and puriﬁcation has been Escherichia coli (E. coli), for which
many strains and expression systems are available. However, het-
erologous protein expression in E. coli is not always 100% suitable;
appropriate post-translational modiﬁcations such as glycosylations
are not introduced, and protein expression in E. coli can result in
improper protein folding/functionality and sub-optimal expression
yields (Samuelson, 2011; Angov et al., 2011; Francis and Page, 2010;
Saida, 2007). On the other hand, the choice among systems avail-
able for protein production in Gram-positive bacteria is limited,
and these methods are not applicable in all bacterial strains and for
all proteins (Noreen et al., 2011; Linares et al., 2010; Conrad et al.,
1996; Warren et al., 2005; Fukatsu et al., 2005; Biswas et al., 2008;
Fujimoto and Ike, 2001).
For these reasons, the strengths and limitations of different
prokaryotic expression systems have to be evaluated. If applica-
ble, homologous protein production in the natural host is often
preferable. Autologous host background offers substantial advan-
tages where protein function is associated with other indigenous
accessory factors, or when biochemical assays to evaluate protein
Open access under CC BY-NC-ND license.functionality are not available.
Among the existing Gram-positive expression systems, to our
knowledge no speciﬁc methods have been designed for homol-
ogous protein over-expression/puriﬁcation in S. pneumoniae.
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ffective expression systems are needed to assess protein
unctionality concurrently facilitating recombinant homolo-
ous production of wild type (wt) or mutant pneumococcal
roteins for further applications (i.e. through mutagene-
is/complementation/puriﬁcation assays).
The shuttle plasmid pMU1328, originally designed to detect
NA fragments exhibiting promoter activity in different Strepto-
occal species (Achen et al., 1986; Lakshmidevi et al., 1990), is
ne of the systems used to complement protein expression in S.
neumoniae deletion mutants (Sung et al., 2001; Gentile et al.,
011; Espinosa and Nieto, 2003; Bartilson et al., 2001; Pericone
t al., 2003; Yother et al., 1992). pMU1328 efﬁciently replicates in
oth E. coli and S. pneumoniae, contains an erythromycin resistance
arker, and is easy to manipulate due to the presence of the M13mp
8 polylinker.
In this work, we evaluated the use of the plasmid pMU1328
nd the natural constitutive pneumococcal promoter P96 to over-
xpress and purify homologous proteins in S. pneumoniae. Genes
oding for pneumococcal proteins with different sub-cellular
ocalizations (secreted, membrane and cell wall anchored) were
ntroduced in the pMU1328 shuttle vector under the transcriptional
ontrol of either P96 or the constitutive erythromycin promoter.
he obtained plasmids were then transformed in site-speciﬁc
. pneumoniae knock-out deletion mutants of the correspond-
ng genes and the relative promoter strength in pneumococcus
as investigated and compared with single-copy expression from
he integrated chromosomal location. His-tagged pneumococcal
rgB lacking the cell wall anchor motif served as a model pro-
ein to validate the design of efﬁcient pMU1328-P96 mediated
xpression and secretion, followed by one step puriﬁcation of the
rotein.
. Material and methods
.1. Pneumococcal cultures and sample preparation
S. pneumoniae strains (wild type, deletion mutants and comple-
ented deletion mutants) used in this study are listed in Table 1.
acteria were routinely grown at 37 ◦C in 5% CO2. Following over
ight (o.n.) growth on Tryptic Soy Agar plates (TSA, Becton Dick-
nson) supplemented with colistine 10 mg/l, oxolinic acid 5 mg/l
nd 5% deﬁbrinated sheep blood (vol/vol) bacteria were inoculated
n Todd Hewitt Broth (Becton Dickinson) supplemented with 0.5%
w/w) yeast extract (THYE) and grown until A600 = 0.5. Kanamycin
00 g/ml and/or erythromycin 1 g/ml were added to the solid
nd liquid media when needed. To prepare bacterial lysates, the
acteria were harvested from liquid cultures by centrifugation
able 1
ist of the S. pneumoniae strains used in this study.
S. pneumoniae strain Relevant characteristicsa
TIGR4 Serotype 4 strain TIGR4 
D39  Serotype 2 strain D39 
TIGR4/pMU1328 TIGR4/empty pMU1328 (ErmR) 
D39/pMU1329 D39/empty pMU1328 (ErmR) 
D3996  D39 96::kan (KanR) 
D3996/Pc-96  D3996/pMU1328 Pc-spr0096 (K
D3996/P96-96 D3996/pMU1328 P96-spr0096 (K
TIGR4rrgB TIGR4  rrgB::kan(KanR) 
TIGR4rrgB/Pc-rrgB  TIGR4rrgB/pMU1328 Pc-rrgB(Ka
TIGR4rrgB/P96-rrgB TIGR4rrgB/pMU1328 P96-rrgB(K
TIGR4srtC1-3  TIGR4srtC1-2-3:kan(KanR) 
TIGR4srtC1-3/Pc-srtC-2  TIGR4srtC1-3/pMU1328 Pc-srtC-
TIGR4srtC1-3/P96-srtC-2 TIGR4srtC1-3/pMU1328 P96-srtC
TIGR4PI-1 TIGR4  rlrA-rrgABC-srtC1-2-3::kan(
TIGR4PI-1/P96-rrgBHis TIGR4PI-1/pMU1328 P96-rrgBHi
a ErmR: erythromycin resistant; KanR: kanamycin resistant;/: transformed with the pMhnology 157 (2012) 279– 286
and lysed at 37 ◦C for 20 min  in a buffer containing 0.3 M sodium
deoxycholate, 0.02% sodium dodecyl sulphate and 0.2% sodium
citrate. Growth supernatants, when needed, were recovered and
ﬁltered (0.2 m).  Lysates and supernatants were stored at −20 ◦C
until further analysis.
2.2. Sera
Rabbit sera against recombinant His-tagged proteins
expressed/puriﬁed from E. coli (RrgB-His, Spr0096-His and
SrtC-2-His) were obtained by immunizing New Zealand rab-
bits of 2.5 kg body weight (Charles River Laboratory) with
100 g of the puriﬁed proteins (Gianfaldoni et al. (2007) and
unpublished data) (three doses subcutaneous immunization
two weeks apart). Animal treatments were done in compliance
with the current law, and authorized by the Italian Ministry of
Health. Anti His-Tag antibodies (rabbit) were purchased from
Sigma.
2.3. Generation of S. pneumoniae deletion mutants
TIGR4 and D39 isogenic mutants were generated by allelic
exchange. Brieﬂy, fragments of approximately 500 bp upstream
and downstream the target genes were ampliﬁed by PCR and
spliced into a kanamycin resistance cassette (oligonucleotides are
listed in Table 2) by using overlap extension PCR (complementary
nucleotide fragments are indicated in Table 2). The PCR fragments
were then cloned into pGEMt (Promega) and transformed in S.
pneumoniae with conventional methods (Alloing et al., 1998). Selec-
tion of Kanamycin resistant transformants was  performed on plates
supplemented with kanamycin (500 g/ml) and insertion was con-
ﬁrmed by PCR and Western blot (WB) analysis.
2.4. pMU1328 cloning and S. pneumoniae transformation
The pMU1328 recombinant plasmids used in this work (Achen
et al., 1986) were obtained as described below. Brieﬂy, the pneumo-
coccal genes (spr0096, srtC-2 and rrgB) and the spr0096 promoter
region (P96), corresponding to the intergenic region between
the spr0095 and spr0096 genes, were ampliﬁed on the S. pneu-
moniae TIGR4 genomic DNA, while the erythromycin resistance
(ermB) constitutive promoter (Pc), deriving from the pVA838 shut-
tle vector (NCBI accession number: AB057644 and (Achen et al.,
1986)), was ampliﬁed on the pMU1328 plasmid (primers used
are listed in Table 3). Each gene ampliﬁcation product was fused
by overlap extension PCR to either the Pc or the P96 promoter
regions. The obtained PCR products were then digested with the
Source
Laboratory strain
Laboratory strain
This study
This study
This study
anR, ErmR) This study
anR, ErmR) This study
Gentile et al. (2011)
nR, ErmR) Gentile et al. (2011)
anR, ErmR) This study
De Angelis et al. (2011)
2(KanR, ErmR) De Angelis et al. (2011)
-2(KanR, ErmR) This study
KanR) This study
s(KanR, ErmR) This study
U1328 plasmid.
M. Lo Sapio et al. / Journal of Biotechnology 157 (2012) 279– 286 281
Table 2
Oligonucleotides used to create deletion mutants in TIGR4 and D39 wt  strains.
Ampliﬁcation products Primer for (5′–3′)a Primer rev (5′–3′) a
Kan cassette GTCATGATGGCCTAAGTGGCCAACCTGCAGGAACAGTGAATTGGAGTT CGATGCAAATTTTAATGCCGGCTAGATCTAGGTACTAAAACAATTCATC
96 upstream AATTGTCGACTGGAATTCAACTTCTGTTGGAGTA GTTGGCCACTTAGGCCATCATGACGTTATCAATGTGGTTGTTTTCTGC
96 downstream CTAGCCGGCATTTAAATTTGCATCGGTTGTTTCAACTGTAAGCGGATCT TTTAGCGGCCGCTCAACGTTTATATGACTTGCGAAT
rrgB  upstream AATTGTCGACATTATTATTGTCATGTGTAATTCA GTTGGCCACTTTGGCCATCATGACTCCATCTTCACCGACATAAGTTGA
rrgB  downstream CTAGCCGGCATTAAAATTTGCATCGAAGCTGCTTATAATGCTGCTGTGA TTTAGCGGCCGCGCAAGTTGATCCTCATCTTTGTTG
srtC1-3 upstream AATTGTCGACTCTGTTAGGAAAAGCGATAAAATG GTTGGCCACTTAGGCCATCATGACCAGTACCAGCATAAACCGGCAA
srtC1-3 downstream CTAGCCGGCATTTAAATTTGCATCGAACCTCTCAATGGTTGTACCGTGG TTTAGCGGCCGCACCAATAAAGAGATTTTAGACAAG
PI-1  upstream AATTGTCGACTATAATCTCCACAGTGGGATTTAC GTTGGCCACTTAGGCCATCATGACCAGATGTAAACTTAATAAAGTCCA
PI-1 downstream CTAGCCGGCATTTAAATTTGCATCGCAGGGATTCGCTCAGTGATTGCTG TTTAGCGGCCGCACAAAGAGCCGGAAAAAGGAACAG
a Italic letters represent complementary sequences added to perform the overlap extention PCR.
Table 3
Oligonucleotides used to clone the genes of interest under the control of either Pc or P96 in the pMU1328 vector.
Plasmid Ampliﬁcation primers (5′–3′)a,b,c
Promoter region Gene
pMU1328 Pc-spr0096 For GTGCGTGAATTCGAAACAGCAAAGAATGGCGGAAAC For TTGTAATTAAGAAGGAGTGATTACATGAAATCAATAACTAAAAAGATT
Rev GTAATCACTCCTTCTTAATTACAA Rev CAGCGTGTCGACGTTCGTTAGTTCTTAATACCAGCC
pMU1328 P96-spr0096 For GTGCGTGGATCCGATGATATCAAAGACAGATTGAAA Rev CAGCGTGTCGACGTTCGTTAGTTCTTAATACCAGCC
pMU1328 Pc-rrgB For GTGCGTGAATTCGAAACAGCAAAGAATGGCGGAAAC For TTGTAATTAAGAAGGAGTGATTACATGAAATCAATCAACAAATTTTTA
Rev GTAATCACTCCTTCTTAATTACAA Rev CAGCGTGTCGACTGGCTCCTTTCTCTCTTACTTAAG
pMU1328 P96-rrgB For GTGCGTGGATCCGATGATATCAAAGACAGATTGAAA For TAGAAAGAAGGAGAATTTTCGAATATGAAATCAATCAACAAATTTTTA
Rev ATTCGAAAATTCTCCTTCTTTCTA Rev CAGCGTGTCGACTGGCTCCTTTCTCTCTTACTTAAG
pMU1328 P96-rrgBHis For GTGCGTGGATCCGATGATATCAAAGACAGATTGAAA For TAGAAAGAAGGAGAATTTTCGAATATGAAATCAATCAACAAATTTTTA
Rev ATTCGAAAATTCTCCTTCTTTCTA Rev CAGCGTGTCGACTTAatggtgatggtgatggtgAGTGATTTTTTTGTTGACTACTTT
pMU1328 Pc-srtC-2 For GTGCGTGAATTCGAAACAGCAAAGAATGGCGGAAAC For TTGTAATTAAGAAGGAGTGATTACATGGACAACAGTAGACGTTCACGA
Rev GTAATCACTCCTTCTTAATTACAA Rev CAGCGTGTCGACCGTAGTTTAGTCCTTGACATGACG
pMU1328 P96-srtC-2 For GTGCGTGGATCCGATGATATCAAAGACAGATTGAAA For TAGAAAGAAGGAGAATTTTCGAATATGGACAACAGTAGACGTTCACGA
Rev ATTCGAAAATTCTCCTTCTTTCTA Rev CAGCGTGTCGACCGTAGTTTAGTCCTTGACATGACG
a Underlined sequences correspond to the restriction recognition sites.
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c Italic letters represent complementary sequences added to perform the overlap
ppropriated restriction enzymes (Table 3), and cloned into the
omplementation plasmid pMU1328, containing an erythromycin
esistance marker (Achen et al., 1986). The ligation mixtures were
ransformed into competent cells of Escherichia coli DH10B. Selec-
ion of erythromycin resistant transformants was performed on
lates supplemented with erythromycin (100 g/ml) and inser-
ion was conﬁrmed by sequencing. D39 or TIGR4 wt  or deletion
utants strains were then transformed with conventional methods
Alloing et al., 1998) by using the obtained plasmids or the empty
MU1328 plasmid at a ﬁnal concentration of 50 ng/ml. S. pneu-
oniae transformants (25–100 single colonies), selected on TSA
lates supplemented with 5% deﬁbrinated sheep blood (vol/vol)
nd antibiotics (erythromycin 1 g/ml with or without kanamycin
00 g/ml), were analyzed by PCR to conﬁrm the presence of the
lasmid and further investigated for the expression of the pro-
eins of interest. The transformation frequency (TF), measured as
he ratio of the number of colonies obtained in the presence of
he selective antibiotic to the number of colonies without antibi-
tic selection was 2.5 × 10−5 (±1.5 × 10−5) for D39 and 1. 5 × 10−5
±2 × 10−5) for TIGR4 (comparable to the TFs obtained with the
uicide vectors used to create site-speciﬁc knock-out deletion
utants).
.5. Relative quantitative real-time PCR quantiﬁcation of
MU1328 copy number in S. pneumoniae and E. coliThe quantiﬁcation of the pMU1328 copy number relative to the
hromosomal DNA was evaluated in E. coli and S. pneumoniae by
uantitative real-time PCR (qRT-PCR) analysis. The primers used
or qRT-PCR analysis are reported in Table 4. The oligonucleotidesers.
sion PCR.
were designed to speciﬁcally amplify about 300 bp fragments on a
single copy gene in the chromosomal DNA (reference) of E. coli or S.
pneumoniae (GAPDH, glyceraldehyde 3-phosphate dehydrogenase)
and onto a unique sequence in the pMU1328 plasmid (target). The
qRT-PCR reaction was performed in a Light Cycler 480 II (Roche),
by using the Light Cycler SYBR green I Master (Roche) according to
the manufacturer’s instructions. Comparable results were obtained
for total DNA samples prepared with conventional methods and
heat-lyzed bacteria (100 ◦C for 15 min). For each gene, duplicate
reactions were performed on 10 fold serially diluted bacterial sam-
ples isolated from separate assays. The PCR conditions included
a single denaturation cycle of 95 ◦C for 10 min, followed by 45
cycles of 95 ◦C for 10 s (denaturation), 60 ◦C for 30 s (annealing)
and 72 ◦C for 30 s (elongation). Melting curves and agarose gels
were used to determine the speciﬁcity of the ampliﬁcation. Relative
quantiﬁcation analyses (ratio target/reference) were performed
with Light Cycler® 480 SW 1.5 (Roche).
2.6. RrgB-His SP protein puriﬁcation from S. pneumoniae culture
supernatants
S. pneumoniae TIGR4PI-1/P96-rrgB-His strain was grown in
THYE supplemented with erythromycin (1 g/ml) and kanamycin
(500 g/ml). Following bacteria harvesting by centrifugation, the
supernatants were ﬁltered (0.2 m),  dialyzed o.n. against 100 mM
sodium phosphate buffer pH 6.3 and then supplemented with
100 mM sodium chloride and 20 mM imidazole ﬁnal concen-
trations. The RrgB-His SP protein was then puriﬁed by metal
chelate afﬁnity chromatography on columns packed with Chelat-
ing Sepharose HP (GE Healthcare) eluting with a 100 mM sodium
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hosphate buffer pH 6.3 supplemented with 100 mM sodium chlo-
ide and 500 mM imidazole. Protein purity was determined by
DS-PAGE. The fractions containing the puriﬁed protein were
tored at −80 ◦C until further use. Protein concentration was
stimated by both SDS-PAGE and NanoDrop (Thermo Scientiﬁc)
easurement.
.7. SDS-PAGE and Western blot analysis
SDS-PAGE analysis was  performed using Nu-PAGETM 4–12%
is–Tris gradient gels (Invitrogen) according to manufacturer
nstructions. See blue plus 2TM pre-stained MW (Invitrogen) served
s protein standard. Gels were stained with Colloidal Coomassie
lue G-250 (Invitrogen) or processed for WB analysis by using
tandard protocols. Rabbit antibodies raised against recombi-
ant His-Tag-proteins and rabbit anti His-Tag antibodies were
sed at 1:10,000 and 1:2000 dilution, respectively. Secondary
oat anti-rabbit IgG alkaline phosphatase conjugated antibod-
es (Promega) were used at 1:5000 and the signal developed by
sing Western Blue Stabilized Substrate for Alkaline Phosphatase
Promega).
.8. N-terminal sequencing of RrgB-His SP by Edman degradation
Automatic N-terminal sequencing of the ﬁrst six amino acid
esidues of RrgB-His SP was carried out on an Applied Biosys-
ems instrument Model H49 Procise protein/peptide sequencer
ollowing manufacturer’s instructions. Before sequencing, about
 g of the puriﬁed protein solution were passed through a
roSorb PVDF cartridge (Applied Biosystems); the cartridge was
ashed several times with 0.1% triﬂuoroacetic acid to remove salts
resent in the protein preparation and then the sample loaded for
equencing.
.9. Enzymatic digestion of the proteins
RrgB-His SP and two pneumococcal recombinant proteins puri-
ed from E. coli, RrgB-His and the beta galactosidase BgaA (Spr0565,
6 strain annotation) (Gianfaldoni et al. (2007) and unpublished
ata), were digested with sequencing grade modiﬁed Trypsin
Promega), using a ratio enzyme/substrate of 1/100 (wt/wt), in
0 mM HEPES pH 7.5 and 200 mM NaCl. o.n. at room temperature
procedure 1) (El Mortaji et al., 2010), or in 50 mM ammonium
icarbonate pH 8, containing 0.1% (w/v) Rapigest® (Waters) o.n.
t 37 ◦C (procedure 2) (Moschioni et al., 2010).
able 4
rimers used in QRT-PCR for the relative quantiﬁcation of pMU1328 copy number.
Ampliﬁed genes Primer for (5′–3′) 
GAPDH–S. pneumoniae AGAAGGTGTTGAAGTTACACGC 
GAPDH–E. coli CCACGGCGGTAATTTCCGTTTGCG 
pMU1328 GTCTATCAATGTGCCGAAGTGTTG hnology 157 (2012) 279– 286
3. Results and discussion
3.1. The promoter region P96 activates the transcription of
spr0096 more efﬁciently than the erythromycin constitutive
promoter
The pneumococcal Spr0096 (R6 protein annotation, Hoskins
et al. (2001)) is a protein containing LysM peptidoglycan-binding
domains, which is conserved in many S. pneumoniae strains. This
protein is constitutively expressed under standard growth condi-
tions, and actively secreted into the culture media (Ng et al. (2005)
and unpublished data).
In the context of mutagenesis/complementation studies in
the serotype 2 D39 strain, to restore the expression of Spr0096
in D3996 (spr0096 deletion mutant in D39 background), the
spr0096 gene was  inserted in the pMU1328 shuttle vector under
the control of either the erythromycin constitutive promoter (Pc)
(pMU1328 Pc-spr0096), or the intergenic region upstream spr0096
(comprised between the spr0095 and spr0096 genes), here named
P96 (pMU1328 P96-spr0096). Pc is a promoter region already used
for complementation experiments (De Angelis et al., 2011), while
the ability of P96 to promote gene transcription was  not inves-
tigated thus far. Spr0096 expression was  analyzed by western
blot on growth supernatants of D39 and D39 complemented
mutants (D3996/Pc-96 and D3996/P96-96), by using D3996
as negative control. Interestingly, the expression of Spr0096 in
D3996/Pc-96 was  barely detectable, while in D3996/P96-96
supernatants was signiﬁcantly higher than in wt D39. This provides
evidence that P96 contains the spr0096 natural promoter region,
which actively induces the transcription of spr0096 within the
pMU1328 plasmid at higher efﬁciency than Pc (Fig. 1). Indeed,
two additional observations support the presence of a promoter
region within P96: (i) sequence analysis performed with BPROM
(http://linux1.softberry.com/berry.phtml?topic = bprom&group
= programs&subgroup = gﬁndb) revealed the presence of putative
-10/-35 promoter sequences within the P96 intergenic region
(-10 TAATAT and -35 TTTCTA); and (ii) a literature report indi-
cating that this region is directly bound by the Vic regulator
protein (VicR), which is implicated in pneumococcal virulence
(Ng et al., 2005).
Interestingly, according with the data obtained with the wild
type D39 strain (unpublished data), we did not observe any
modulation in the P96 promoter activity when inserted into
the pMU1328 plasmid; in fact, the expression level of Spr0096
remained unchanged growing D3996/Pc-96 and D3996/P96-96
in the presence or absence of erythromycin antibiotic selection
(even following several passages) and under various growth con-
ditions (different media and growth phases, data not shown).
In order to characterize the pMU1328 expression system and
further compare the activity of the two  promoter regions, we  cal-
culated (for pMU1328 Pc-spr0096 and pMU1328 P96-spr0096) the
average plasmid copy number/cell in S. pneumoniae D39 by using
a real-time PCR based method (see Section 2). We  determined
an average of 5.2 ± 0.8 pMU1328 copies/cell, regardless of the
pMU1328 construct tested. This result explains the lower Spr0096
expression observed in D39 wt  with respect to D3996/P96-96 (one
copy vs approximately 5 copies of spr0096 under the control of the
same promoter), and suggests that the P96 promoter region could
Primer rev (5′–3′)
CATGAAGCACCTGAGATAACTG
AGTCGGCACGATGACGACCATTCA
GGCTATTTGCGAGCCACTGAGGTA
Biotec
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e more efﬁcient than Pc in inducing protein expression in pneu-
ococci. In addition, comparable copy number/cell values were
btained transforming D39 with the pMU1328 empty vector, as
ell as the serotype 4 TIGR4 strain with all the generated plas-
ids, indicating that pMU1328 can be reproducibly used to restore
rotein expression in S. pneumoniae.
Since pMU1328 efﬁciently replicates in E. coli bacterial cells, we
valuated the pMU1328 copies/cells in E. coli (DH10B strain), and
ound it to be 105.7 ± 15.5, regardless of the pMU1328 construct
ested.
.2. The promoter region P96 efﬁciently induces the expression of
. pneumoniae proteins with different sub-cellular localizations
Given the good expression levels obtained with the P96 promoter
ith respect to Pc (with comparable plasmid copy numbers/cell),
e sought to determine if this promoter region could efﬁciently
nduce the expression of proteins other than Spr0096 and with
ifferent sub-cellular localizations. Genes coding for a membrane
ssociated enzyme, SrtC-2, and for a cell-wall LPXTG surface
nchored protein, RrgB, were inserted in the pMU1328 plasmid
nder the transcriptional control of either P96 or Pc (Table 3).
he srtc-2 and rrgB genes are both contained in the pilus islet-1
PI-1) genomic region, which speciﬁcally codes for the proteins
ecessary to assemble the pilus-1 structure on the pneumococcal
urface. In detail, rrgB encodes the RrgB pilus-1 backbone, while
rtC-2 codes for SrtC-2, one of the three sortases (namely SrtC-1,
rtC-2 and SrtC-3) which covalently assemble the pilus subunits
n the bacterial surface (Barocchi et al., 2006; Manzano et al.,
008).
Since the three sortases are redundant in pneumococcus
Manzano et al., 2008), to simultaneously assess expression and
ig. 2. The membrane enzyme SrtC-2 and the LPXTG surface anchored pilus protein RrgB
n  whole bacterial lysates of the indicated strains was performed with rabbit SrtC-2His a
valuate pilus assembly (HMW-ladder) indicating the presence of a functional homologo
ysates  of the indicated strains with rabbit RrgBHis antiserum.hnology 157 (2012) 279– 286 283
functionality of SrtC-2, the plasmids containing srtC-2 (pMU1328
Pc-srtC-2 and pMU1328 P96-srtC-2) were transformed in a TIGR4
mutant containing the deletion of all the three sortases SrtC-1, 2
and 3 (TIGR4srtC1-3),  which was unable to assemble a functional
pilus. As shown in Fig. 2A the over-expression of SrtC-2 is more
efﬁcient under the control of the P96 promoter as compared with
the Pc promoter and the wt TIGR4 strain. The presence of enzymatic
activity in the homologous over-expressed SrtC-2 was  concurrently
monitored by evaluating the SrtC-2 dependent assembly of the RrgB
pilus backbone subunits, which appears in the WB  as a typical high
molecular weight ladder (Barocchi et al., 2006). As shown in Fig. 2B,
the presence of a high molecular weight RrgB ladder correlates with
SrtC-2 expression.
Noteworthy, a similar difference in expression induced by the
two promoter regions was obtained over-expressing RrgB in a
TIGR4rrgB background (Fig. 2C).
These data indicate that the promoter region P96 can be used to
efﬁciently over-express wt or mutant proteins with membrane, cell
wall associated or secreted sub-cellular localizations in different
background pneumococcal strains.
3.3. The pMU1328-P96 over-expression system can be used to
design homologous pneumococcal protein secretion allowing
simple protein recovery from the bacterial supernatant
Biochemical and structural characterization of proteins puriﬁed
from heterologous systems are not always predictive of the native
state of a protein. In fact, protein misfolding due to different expres-
sion environments can signiﬁcantly change the properties of the
proteins under analysis. For this reason, a method that allows the
over-expression and puriﬁcation of wt  or mutant proteins from a
homologous system is highly desirable.
 are efﬁciently expressed under the control of the promoter region P96 . WB  analysis
ntiserum to conﬁrm protein expression (A), and with rabbit RrgBHis antibodies to
us SrtC-2 (B). (C) RrgB protein expression was  analyzed by WB on whole bacterial
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p
o
p
i
p
h
2
t
L
t
c
s
a
t
t
c
s
c
n
a
c
s
t
∼
(
t
t
t
F
p
y
s
c
a84 M. Lo Sapio et al. / Journal of 
We  thought to evaluate if the combined use of the pMU1328
lasmid and the promoter region P96 could be used as a homologous
ver-expression system in S. pneumoniae. Since the recombinant
rotein TIGR4 RrgB expressed in E. coli has been well character-
zed, a His tagged pneumococcal RrgB (RrgBHis SP) served as model
rotein to prove the efﬁciency of this method.
To over-express a protein that following a puriﬁcation step could
ave been comparable to that puriﬁed from E. coli (El Mortaji et al.,
011; Paterson and Baker, 2011; Spraggon et al., 2010) in charac-
erization studies, RrgBHis SP was expressed without its C-terminal
PXTG cell-wall anchoring domain, thus preventing its polymeriza-
ion in S. pneumoniae (see above). In detail, an rrgB gene fragment,
oding for a full length protein containing the N-terminal leader
equence and a C-terminal His-tag in place of the LPXTG cell wall
nchor, was inserted in pMU1328 under the transcriptional con-
rol of P96 (pMU1328 P96-rrgBHis). This recombinant plasmid was
hen transformed in TIGR4PI-1,  and RrgBHis SP expression was
onﬁrmed by WB.  As shown in Fig. 3A1 and A2, RrgBHis-SP was
ecreted and present as a monomer in both bacterial lysates and
ulture supernatants of TIGR4PI-1/P96-rrgBHis.
Since the recovery of secreted proteins from bacterial super-
atants generally results in simpler puriﬁcation procedures,
voiding expensive extractions and resulting in less host-derived
ontaminations, a direct puriﬁcation of RrgBHis-SP from culture
upernatant was attempted.
RrgBHis-SP was successfully puriﬁed from 250 ml  of cul-
ure supernatant (see Section 2) obtaining 150 g of protein of
95% purity (∼0.6 g RrgBHis SP/ml starting culture at A600 = 0.5)
Fig. 3B). Sequencing of the N-terminus of the protein revealed that
he N-terminal leader sequence was efﬁciently cleaved, despite
he high yields of RrgBHis SP secreted protein, and conﬁrmed that
he mature RrgB form in S. pneumoniae starts with Ala 30 (leader
ig. 1. The genomic region upstream spr0096 (P96) contains a promoter that in S.
neumoniae is more efﬁcient than the erythromycin constitutive promoter. WB anal-
sis was  performed with rabbit Spr0096His antiserum on S. pneumoniae culture
upernatants of the indicated strains (15 l were loaded in each lane). Arrows indi-
ate Spr0096 speciﬁc signals. The signal at about 50 kDa is non-speciﬁc and was  used
s  loading control.
Fig. 3. RrgBHis SP puriﬁcation from 250 ml  of TIGR4PI-1/P96-rrgBHis culture
supernatant. (A1 and A2) WB  analysis was performed with rabbit polyclonal sera
against RrgBHis (panel A1) and rabbit anti His-tag antibodies (panel A2) on culture
supernatants (20 l in each lane) of the indicated strains and on 0.1 g puriﬁed RrgB-
His  SP. TIGR4PI-1/P96-rrgBHis supernatant was  analyzed before (b.d.) and after
dialysis (a.d.). RrgB expression was also analyzed on whole bacterial lysates (P) of
TIGR4 wt  and TIGR4PI-1/P96-rrgBHis and compared to respective supernatants (S).
Samples in panels A1 and A2 are loaded in the same order. (B) Coomassie stained
gel showing the RrgBHis SP afﬁnity chromatography eluted fractions (1–7). 10 l of
each  750 l fraction were loaded. 1 g of BSA (bovine serum albumin) was loaded
as a standard.
sequence cleavage site between Ala 29 and Ala 30). ESI–MS analy-
sis (electrospray ionization mass spectrometry) of the RrgBHis SP
showed that the molecular mass was 65,216.82 Da (calculated mass
65,266.76 Da). This mass is compatible with the presence of three
intra-molecular isopeptide bonds (Paterson and Baker, 2011).
Finally, since RrgB expressed in E. coli is resistant to trypsin
proteolytic cleavage (El Mortaji et al., 2010), digestion proﬁles of
heterologous RrgBHis (puriﬁed from E. coli) and RrgBHis SP were
compared under two  different conditions, named procedure 1 and
procedure 2 (see Section 2). Beta-galactosidase served as positive
control for digestion. As shown in Fig. 4A, when procedure 1 (El
Mortaji et al., 2010) was applied, the two  RrgB proteins revealed
M. Lo Sapio et al. / Journal of Biotechnology 157 (2012) 279– 286 285
Fig. 4. RrgBHis SP puriﬁed from pneumococcal culture supernatants and heterologous RrgB-His puriﬁed from E. coli lysates show similar trypsin digestion patterns. The
digestion of RrgB-His SP, RrgB-His E. coli and of an unrelated protein (beta-galactosidase), used as digestion positive control (ctrl), were performed under two different
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sonditions as detailed in Section 2 (procedure 1, panel A and procedure 2, panel B)
ane.  The presence or absence of trypsin (TRY) during the incubation is indicated by
imilar resistance to proteolysis, but the beta-galactosidase control
esulted only partially digested. In contrast, when using proce-
ure 2 (Fig. 4B) (Moschioni et al., 2010), beta-galactosidase was
ompletely digested, while the two RrgB proteins showed similar
igestion patterns, ultimately indicating that the resistance to pro-
eolysis, identiﬁed as a speciﬁc feature in the recombinant RrgB
rotein expressed in E. coli,  is present also in RrgB expressed in S.
neumoniae.
These data provide a proof of concept that puriﬁcations of man-
geable amounts of homologous pneumococcal protein material
an be obtained by using this method. In particular, this new
ystem could be useful for proteins which are not efﬁciently
xpressed in heterologous systems and for which the native struc-
ure can be obtained or controlled only within the autologous
ost.
. Conclusion
In conclusion, this novel homologous over-expression system
or S. pneumoniae will help to overcome reliability and feasibility
roblems related to heterologous expression; and has the potential
o be used for the homologous expression of all pneumococcal pro-
eins (preferably using site-speciﬁc deletion mutants of the protein
f interest). Protein production in the natural host rather than E. coli
llows proper biochemical, functional and structural studies with
urther implications for therapeutic or vaccine applications. In addi-
ion, the promiscuity of the pMU1328 replicon (Achen et al., 1986;
rooker et al., 1995; Lakshmidevi et al., 1990; Powell et al., 1988)
ndicates its possible use in diverse bacterial species, including
ther streptococcal human pathogens like Streptococcus pyogenes
nd Streptococccus agalactiae.
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